Inflammatory bowel diseases are characterized by an altered composition of gut microbiota
(dysbiosis) that may contribute to their development. Antibiotics can alter the bacterial flora …

The use of antibiotics as primary therapy in inflammatory bowel disease (IBD) has been an
issue of great controversy among the experts in the field. Although the utility of certain …

In evaluating the medical literature dealing with antibiotics and inflammatory bowel
diseases, I cannot help but recall the adage:“Those who have enthusiasm have no controls …

Inflammatory bowel disease is thought to be caused by an aberrant immune response to gut
bacteria in a genetically susceptible host. The gut microbiota plays an important role in the …

A variety of medicines have been used for the treatment of inflammatory bowel disease.
Antibiotics have demonstrated promise by improving symptoms and by causing disease …

Imbalances in the composition and number of bacteria in the gut microbiota have been
implicated in inflammatory bowel disease (IBD), and modulation of the gut microbiota by …

The current model of pathogenesis for inflammatory bowel disease (IBD) is a dysregulated
immune system that is triggered by an environmental factor in a genetically susceptible …

Although antibiotics are clearly recognized as having a role in treating the infectious
complications of inflammatory bowel diseases (IBD), such as systemic sepsis and pelvic …

The aetiology of ulcerative colitis and Crohn's disease remains unknown. While this remains
so, treatment must be directed towards pathogenetic mechanisms. Corticosteroids …

On the assumption that bacteria in the gut may be a cause of symptoms and/or
complications of Crohn's disease, various antibiotics are efficaciously employed in some …